{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:45:23Z","timestamp":1792154723689,"version":"4.4.0"},"reference-count":156,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.endien.2026.501821","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:17:12Z","timestamp":1792149432000},"page":"501821","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Growth hormone therapy in Turner syndrome: Do cytogenetic subtypes influence outcomes?"],"prefix":"10.1016","volume":"73","author":[{"given":"Ingrid-Ioana","family":"Her\u0219covici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Cristina P\u00e2nzaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgiana","family":"Constantinescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leti\u021bia","family":"Leu\u0219tean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Christina","family":"Ungureanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Preda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Rusu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.endien.2026.501821_bib0785","doi-asserted-by":"crossref","first-page":"223","DOI":"10.5582\/irdr.2017.01056","article-title":"A basic understanding of Turner syndrome: incidence, complications, diagnosis, and treatment","volume":"7","author":"Cui","year":"2018","journal-title":"Intractable Rare Dis Res"},{"key":"10.1016\/j.endien.2026.501821_bib0790","first-page":"192","article-title":"Advances in the study of the diagnosis and treatment of Turner syndrome","volume":"29","author":"Zhang","year":"2015","journal-title":"J China-Japan Friendship Hospital"},{"key":"10.1016\/j.endien.2026.501821_bib0795","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0140-6736(59)91893-8","article-title":"A sex-chromosome anomaly in a case of gonadal dysgenesis (Turner's syndrome)","volume":"1","author":"Ford","year":"1959","journal-title":"Lancet"},{"key":"10.1016\/j.endien.2026.501821_bib0800","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/GIM.0b013e3181c684b2","article-title":"Laboratory guideline for Turner syndrome","volume":"12","author":"Wolff","year":"2010","journal-title":"Genet Med"},{"key":"10.1016\/j.endien.2026.501821_bib0805","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/jcdd8110138","article-title":"A review of recent developments in Turner syndrome research","volume":"8","author":"Huang","year":"2021","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.endien.2026.501821_bib0810","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.rpped.2014.11.014","article-title":"S\u00edndrome de Turner e polimorfismo gen\u00e9tico: uma revis\u00e3o sistem\u00e1tica","volume":"33","author":"Trov\u00f3 de Marqui","year":"2015","journal-title":"Rev Paul Pediatr"},{"key":"10.1016\/j.endien.2026.501821_bib0815","first-page":"873","article-title":"Turner syndrome. From child to adult. A multidisciplinary approach","volume":"23","author":"Santos","year":"2010","journal-title":"Acta Med Port"},{"key":"10.1016\/j.endien.2026.501821_bib0820","doi-asserted-by":"crossref","first-page":"17","DOI":"10.21037\/pm-22-9","article-title":"Turner syndrome: narrative review of genetics and clinical aspects of management","volume":"7","author":"Fudge","year":"2024","journal-title":"Pediatr Med"},{"key":"10.1016\/j.endien.2026.501821_bib0825","first-page":"94","article-title":"Exclusion of chromosomal mosaicism: tables of 90%, 95% and 99% confidence limits and comments on use","volume":"29","author":"Hook","year":"1977","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.endien.2026.501821_bib0830","doi-asserted-by":"crossref","first-page":"711","DOI":"10.7863\/jum.2006.25.6.711","article-title":"Prenatal diagnosis of Turner syndrome","volume":"25","author":"Papp","year":"2006","journal-title":"J Ultrasound Med"},{"key":"10.1016\/j.endien.2026.501821_bib0835","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1067\/mob.2003.230","article-title":"A characteristic cluster of fetal sonographic markers that are predictive of fetal Turner syndrome in early pregnancy","volume":"188","author":"Bronshtein","year":"2003","journal-title":"Am J Obstetr Gynecol"},{"key":"10.1016\/j.endien.2026.501821_bib0840","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0140-6736(01)05487-3","article-title":"Turner's syndrome","volume":"358","author":"Ranke","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.endien.2026.501821_bib0845","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1210\/jc.2012-1245","article-title":"Clinical review: Turner syndrome: updating the paradigm of clinical care","volume":"97","author":"Pinsker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib0850","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1210\/jcem.84.12.6289","article-title":"Skeletal features and growth patterns in 14 patients with haploinsufficiency of SHOX: implications for the development of Turner syndrome","volume":"84","author":"Kosho","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib0855","first-page":"864","article-title":"Methylation patterns in human androgen receptor gene and clonality analysis","volume":"60","author":"Jang","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.endien.2026.501821_bib0860","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0163-7258(99)00043-1","article-title":"DNA methylation analysis a review of current methodologies","volume":"84","author":"Oakeley","year":"1999","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.endien.2026.501821_bib0865","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-2001-15394","article-title":"Molecular analysis of genes on Xp controlling Turner syndrome and premature ovarian failure (POF)","volume":"19","author":"Zinn","year":"2001","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.endien.2026.501821_bib0870","article-title":"Recombinant growth hormone for children and adolescents with Turner syndrome","volume":"1","author":"Baxter","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.endien.2026.501821_bib0875","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/cen.13394","article-title":"The Turner syndrome life course project: karyotype\u2013phenotype analyses across the lifespan","volume":"87","author":"Cameron-Pimblett","year":"2017","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.endien.2026.501821_bib0880","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-17-0430","article-title":"Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting","volume":"177","author":"Gravholt","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endien.2026.501821_bib0885","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1365-2265.2007.02807.x","article-title":"Chromosomal mosaicism mitigates stigmata and cardiovascular risk factors in Turner syndrome","volume":"66","author":"El-Mansoury","year":"2007","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.endien.2026.501821_bib0890","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/humrep\/dew012","article-title":"Spontaneous fertility and pregnancy outcomes amongst 480 women with Turner syndrome","volume":"31","author":"Bernard","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.endien.2026.501821_bib0895","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.fertnstert.2010.12.039","article-title":"Pregnancy rate and outcome in Swedish women with Turner syndrome","volume":"95","author":"Bryman","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.endien.2026.501821_bib0900","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0140-6736(94)91028-6","article-title":"Y chromosome sequences in Turner's syndrome and risk of gonadoblastoma or virilisation","volume":"343","author":"Page","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.endien.2026.501821_bib0905","doi-asserted-by":"crossref","first-page":"G53","DOI":"10.1093\/ejendo\/lvae050","article-title":"Clinical practice guidelines for the care of girls and women with Turner syndrome","volume":"190","author":"Gravholt","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endien.2026.501821_bib0910","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ejmg.2013.07.008","article-title":"Buccal cell FISH and blood PCR-Y detect high rates of X chromosomal mosaicism and Y chromosomal derivatives in patients with Turner syndrome","volume":"56","author":"Freriks","year":"2013","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.endien.2026.501821_bib0915","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ajmg.a.30002","article-title":"Phenotype and X inactivation in 45, X\/46, X,r(X) cases","volume":"128A","author":"Leppig","year":"2004","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.endien.2026.501821_bib0920","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ajmg.1320520204","article-title":"Mental retardation and Ullrich\u2013Turner syndrome in cases with 45, X\/46, X,+ mar: additional support for the loss of the X-inactivation center hypothesis","volume":"52","author":"Cole","year":"1994","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.endien.2026.501821_bib0925","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1068128","article-title":"Growth in girls with Turner syndrome","volume":"13","author":"Isojima","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.endien.2026.501821_bib0930","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1210\/jc.2009-0926","article-title":"Approach to the patient with Turner syndrome","volume":"95","author":"Davenport","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib0935","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1210\/jc.2013-1222","article-title":"GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trial","volume":"98","author":"Blum","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib0940","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1210\/jc.2005-0470","article-title":"Adult height and pubertal growth in Turner syndrome after treatment with recombinant growth hormone","volume":"90","author":"Soriano-Guillen","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib0945","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1530\/EJE-15-1000","article-title":"X-chromosome gene dosage as a determinant of impaired pre- and postnatal growth and adult height in Turner syndrome","volume":"174","author":"Fiot","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endien.2026.501821_bib0950","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3390\/endocrines3020022","article-title":"Turner syndrome","volume":"3","author":"Clemente","year":"2022","journal-title":"Endocrines"},{"key":"10.1016\/j.endien.2026.501821_bib0955","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrendo.2010.123","article-title":"The growth hormone receptor: mechanism of activation and clinical implications","volume":"6","author":"Brooks","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.endien.2026.501821_bib0960","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1210\/er.2016-1036","article-title":"A track record on SHOX: from basic research to complex models and therapy","volume":"37","author":"Marchini","year":"2016","journal-title":"Endocr Rev"},{"key":"10.1016\/j.endien.2026.501821_bib0965","first-page":"90","article-title":"Adult height in Turner syndrome: results of a multinational survey 1993","volume":"42","author":"Ranke","year":"1994","journal-title":"Horm Res"},{"key":"10.1016\/j.endien.2026.501821_bib0970","doi-asserted-by":"crossref","first-page":"240","DOI":"10.6065\/apem.2017.22.4.240","article-title":"Development of disease-specific growth charts in Turner syndrome and Noonan syndrome","volume":"22","author":"Isojima","year":"2017","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib0975","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1297\/cpe.19.69","article-title":"Proposal of new auxological standards for Japanese girls with Turner syndrome","volume":"19","author":"Isojima","year":"2010","journal-title":"Clin Pediatr Endocrinol"},{"key":"10.1016\/j.endien.2026.501821_bib0980","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1297\/cpe.19.69","article-title":"Proposal of new auxological standards for Japanese girls with Turner syndrome","volume":"19","author":"Isojima","year":"2010","journal-title":"Clin Pediatr Endocrinol"},{"key":"10.1016\/j.endien.2026.501821_bib0985","first-page":"69","article-title":"Perspectives on growth promoting treatment for patients with Turner syndrome in Japan","volume":"19","author":"Tanaka","year":"2020","journal-title":"Clin Pediatr Endocrinol"},{"key":"10.1016\/j.endien.2026.501821_bib0990","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1210\/jc.2004-2187","article-title":"Impact of growth hormone supplementation on adult height in Turner syndrome: results of the Canadian randomized controlled trial","volume":"90","author":"Stephure","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib0995","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1056\/NEJMoa1005669","article-title":"Growth hormone plus childhood low-dose estrogen in Turner's syndrome","volume":"364","author":"Ross","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.endien.2026.501821_bib1000","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1210\/clinem\/dgaa274","article-title":"Growth and adult height in girls with Turner syndrome following IGF-1 titrated growth hormone treatment","volume":"105","author":"Cleemann Wang","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib1005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/687978","article-title":"Growth curves for girls with Turner syndrome","volume":"2014","author":"Bertapelli","year":"2014","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.endien.2026.501821_bib1010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251810169","article-title":"The effects of growth hormone treatment beyond growth promotion in patients with genetic syndromes: a systematic review of the literature","volume":"25","author":"Kucharska","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.endien.2026.501821_bib1015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1210\/endrev\/bnac016","article-title":"The changing face of Turner syndrome","volume":"44","author":"Gravholt","year":"2022","journal-title":"Endocr Rev"},{"key":"10.1016\/j.endien.2026.501821_bib1020","first-page":"29","article-title":"Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center","volume":"91","author":"Al Shaikh","year":"2020","journal-title":"Acta Biomed"},{"key":"10.1016\/j.endien.2026.501821_bib1025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000515875","article-title":"Safety and effectiveness of recombinant human growth hormone in children with Turner syndrome: data from the PATRO children study","volume":"94","author":"Backeljauw","year":"2021","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.endien.2026.501821_bib1030","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1530\/eje.0.1510567","article-title":"Early treatment with GH alone in Turner syndrome: prepubertal catch-up growth and waning effect","volume":"151","author":"Wasniewska","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endien.2026.501821_bib1035","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/er.2008-0027","article-title":"Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects","volume":"30","author":"M\u00f8ller","year":"2009","journal-title":"Endocr Rev"},{"key":"10.1016\/j.endien.2026.501821_bib1040","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.beem.2016.11.012","article-title":"muscle and skeletal health in children and adolescents with GH deficiency","volume":"30","author":"Improda","year":"2016","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib1045","doi-asserted-by":"crossref","first-page":"78","DOI":"10.33590\/emjdiabet\/10313977","article-title":"Growth hormone and metabolic homeostasis","volume":"6","author":"Nishad","year":"2018","journal-title":"EMJ Diabetes"},{"key":"10.1016\/j.endien.2026.501821_bib1050","first-page":"3786","article-title":"Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency","volume":"85","author":"Sas","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib1055","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2265.2007.02753.x","article-title":"Metabolic effects of growth hormone (GH) replacement in children and adolescents with severe isolated GH deficiency due to a GHRH receptor mutation","volume":"66","author":"Gleeson","year":"2007","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.endien.2026.501821_bib1060","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1055\/s-0033-1358730","article-title":"Metabolic parameters and adipokine profile in growth hormone deficient (GHD) children before and after 12-month GH treatment","volume":"46","author":"Meazza","year":"2013","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.endien.2026.501821_bib1065","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s40618-014-0184-4","article-title":"Reduction in insulin sensitivity and inadequate \u03b2-cell capacity to counteract the increase in insulin resistance in children with idiopathic growth hormone deficiency during 12 months of growth hormone treatment","volume":"38","author":"Ciresi","year":"2014","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.endien.2026.501821_bib1070","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/pr.2017.271","article-title":"Effect of recombinant human growth hormone therapy on blood lipid and carotid intima\u2013media thickness in children with growth hormone deficiency","volume":"83","author":"Chen","year":"2018","journal-title":"Pediatr Res"},{"key":"10.1016\/j.endien.2026.501821_bib1075","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1093691","article-title":"The influence of growth hormone on pediatric body composition: a systematic review","volume":"14","author":"Ferruzzi","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.endien.2026.501821_bib1080","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/sj.ijo.0801119","article-title":"Body mass index (BMI) in Turner syndrome before and during growth hormone (GH) therapy","volume":"24","author":"Blackett","year":"2000","journal-title":"Int J Obes"},{"key":"10.1016\/j.endien.2026.501821_bib1085","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1210\/jc.2006-1351","article-title":"The effects of growth hormone treatment on bone mineral density and body composition in girls with Turner syndrome","volume":"91","author":"Ari","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib1090","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1210\/jc.2007-2266","article-title":"Reduced abdominal adiposity and improved glucose tolerance in growth hormone-treated girls with Turner syndrome","volume":"93","author":"Wooten","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib1095","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000223419","article-title":"Long-term follow-up of GH-treated girls with Turner syndrome: metabolic consequences","volume":"71","author":"Bannink","year":"2009","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.endien.2026.501821_bib1100","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1542\/peds.110.5.889","article-title":"Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study","volume":"110","author":"Gravholt","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.endien.2026.501821_bib1105","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1530\/eje.0.1510351","article-title":"Insulin sensitivity in Turner's syndrome: influence of GH treatment","volume":"151","author":"Radetti","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endien.2026.501821_bib1110","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000089318","article-title":"Turner syndrome, insulin sensitivity and growth hormone treatment","volume":"64","author":"Mazzanti","year":"2005","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.endien.2026.501821_bib1115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000098440","article-title":"Effects of growth hormone on growth, insulin resistance and related hormones (ghrelin, leptin and adiponectin) in Turner syndrome","volume":"68","author":"Darendeliler","year":"2007","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.endien.2026.501821_bib1120","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1515\/jpem-2020-0266","article-title":"The influence of growth hormone therapy on the cardiovascular system in Turner syndrome","volume":"33","author":"Dyrka","year":"2020","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib1125","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5114\/pedm.2022.123204","article-title":"Metabolic consequences of recombinant human growth hormone therapy in patients with Turner syndrome","volume":"29","author":"Gnaci\u0144ska","year":"2023","journal-title":"Pediatr Endocrinol Diab Metab"},{"key":"10.1016\/j.endien.2026.501821_bib1130","first-page":"240","article-title":"Cardiac performance in Turner's syndrome patients on growth hormone therapy","volume":"55","author":"Radetti","year":"2001","journal-title":"Horm Res"},{"key":"10.1016\/j.endien.2026.501821_bib1135","doi-asserted-by":"crossref","first-page":"518","DOI":"10.55730\/1300-0144.5612","article-title":"Body proportions in patients with Turner syndrome on growth hormone treatment","volume":"53","author":"Derya Kardelen Al","year":"2023","journal-title":"Turkish J Med Sci"},{"key":"10.1016\/j.endien.2026.501821_bib1140","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1046\/j.1365-2265.2000.00963.x","article-title":"A longitudinal study on bone mineral density until adulthood in girls with Turner's syndrome participating in a growth hormone injection frequency-response trial","volume":"52","author":"Sas","year":"2000","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.endien.2026.501821_bib1145","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1203\/00006450-200109000-00019","article-title":"Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner's syndrome participating in a randomized dose\u2013response study","volume":"50","author":"Sas","year":"2001","journal-title":"Pediatr Res"},{"key":"10.1016\/j.endien.2026.501821_bib1150","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1515\/JPEM.2003.16.8.1175","article-title":"Urinary deoxypyridinoline, serum osteocalcin and bone mineral density in girls with Turner's syndrome","volume":"16","author":"Wikiera","year":"2003","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib1155","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1210\/jc.2004-0481","article-title":"Growth hormone therapy and bone mineral density in Turner syndrome","volume":"89","author":"Bakalov","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib1160","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1365-2265.2007.03107.x","article-title":"The effect of growth hormone treatment on bone mineral density in prepubertal girls with Turner syndrome: a multicentre prospective clinical trial","volume":"68","author":"Aycan","year":"2008","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.endien.2026.501821_bib1165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.maturitas.2019.09.010","article-title":"Turner syndrome and osteoporosis","volume":"130","author":"Augoulea","year":"2019","journal-title":"Maturitas"},{"key":"10.1016\/j.endien.2026.501821_bib1170","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1515\/jpem-2022-0516","article-title":"Normal bone density but altered geometry in girls with Turner syndrome","volume":"36","author":"Schweizer","year":"2023","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib1175","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1365-2265.2005.02270.x","article-title":"Effect of growth hormone and 17\u03b2-oestradiol treatment on metabolism and body composition in girls with Turner syndrome","volume":"62","author":"H\u00f8jbjerg Gravholt","year":"2005","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.endien.2026.501821_bib1180","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/cen.14413","article-title":"Skeletal disproportion in girls with Turner syndrome and longitudinal change with growth-promoting therapy","volume":"94","author":"McVey","year":"2021","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.endien.2026.501821_bib1185","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s00784-012-0844-8","article-title":"Ontogenetic changes of craniofacial complex in Turner syndrome patients treated with growth hormone","volume":"17","author":"Juloski","year":"2012","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.endien.2026.501821_bib1190","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.archoralbio.2016.06.012","article-title":"Growth hormone positive effects on craniofacial complex in Turner syndrome","volume":"71","author":"Juloski","year":"2016","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.endien.2026.501821_bib1195","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/uog.144","article-title":"Pelvic ultrasound evaluation in patients with Turner syndrome during treatment with growth hormone","volume":"22","author":"Sampaolo","year":"2003","journal-title":"Ultrasound Obstetr Gynecol"},{"key":"10.1016\/j.endien.2026.501821_bib1200","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/cen.14957","article-title":"Growth hormone therapy is associated with improved uterine dimensions in girls with Turner syndrome prior to oestrogen replacement","volume":"100","author":"Mondal","year":"2023","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.endien.2026.501821_bib1205","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.1210\/jc.2019-00340","article-title":"Health-related quality of life in Turner syndrome and the influence of growth hormone therapy: a 20-year follow-up","volume":"104","author":"Krantz","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib1210","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3109\/09513590.2013.872236","article-title":"The influence of hormonal replacement and growth hormone treatment on the lipids in Turner syndrome","volume":"30","author":"Irzyniec","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.endien.2026.501821_bib1215","first-page":"769","article-title":"Carbohydrate metabolism during long-term growth hormone (GH) treatment and after discontinuation of GH treatment in girls with Turner syndrome participating in a randomized dose\u2013response study","volume":"85","author":"Sas","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib1220","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jpeds.2005.08.043","article-title":"Quality of life after growth hormone therapy and induced puberty in women with Turner syndrome","volume":"148","author":"Bannink","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.endien.2026.501821_bib1225","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1210\/jc.2009-1754","article-title":"Impact of growth hormone therapy on quality of life in adults with Turner syndrome","volume":"95","author":"Amundson","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib1230","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2431-11-49","article-title":"Health-related quality of life of young adults with Turner syndrome following a long-term randomized controlled trial of recombinant human growth hormone","volume":"11","author":"Taback","year":"2011","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.endien.2026.501821_bib1235","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000085841","article-title":"Psychosocial functioning after discontinuation of long-term growth hormone treatment in girls with Turner syndrome","volume":"63","author":"van Pareren","year":"2005","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.endien.2026.501821_bib1240","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000313964","article-title":"Growth hormone treatment does not affect incidences of middle ear disease or hearing loss in infants and toddlers with Turner syndrome","volume":"74","author":"Davenport","year":"2010","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.endien.2026.501821_bib1245","series-title":"Turner syndrome: growth promoting therapies","first-page":"269","article-title":"Effect of GH and oxandrolone on carbohydrate and lipid metabolism","author":"Wilson","year":"1991"},{"key":"10.1016\/j.endien.2026.501821_bib1250","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000182763","article-title":"Glucose metabolism in Ullrich Turner syndrome: long-term effects of therapy with human growth hormone","volume":"39","author":"Weise","year":"1993","journal-title":"Horm Res"},{"key":"10.1016\/j.endien.2026.501821_bib1255","first-page":"31","article-title":"Growth hormone therapy for Turner syndrome: evidence for benefit","volume":"48","author":"Carel","year":"1997","journal-title":"Horm Res"},{"key":"10.1016\/j.endien.2026.501821_bib1260","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1515\/JPEM.1997.10.1.27","article-title":"Factors predictive of response to growth hormone therapy in Turner's syndrome","volume":"10","author":"Hofman","year":"1997","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib1265","series-title":"Growth hormone therapy in pediatrics \u2013 20 years of KIGS","author":"Ranke","year":"2007"},{"key":"10.1016\/j.endien.2026.501821_bib1270","first-page":"1936","article-title":"Early initiation of growth hormone treatment allows age-appropriate estrogen use in Turner's syndrome","volume":"86","author":"Reiter","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib1275","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1210\/jcem.87.5.8477","article-title":"Growth hormone and low dose estrogen in Turner syndrome: results of a united states multi-center trial to near-final height","volume":"87","author":"Quigley","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib1280","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/jc.2006-1374","article-title":"Care of girls and women with Turner syndrome: a guideline of the Turner syndrome study group","volume":"92","author":"Bondy","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib1285","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0022-3476(86)80272-4","article-title":"Methionyl human growth hormone and oxandrolone in Turner syndrome: preliminary results of a prospective randomized trial","volume":"109","author":"Rosenfeld","year":"1986","journal-title":"J Pediatr"},{"key":"10.1016\/j.endien.2026.501821_bib1290","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1159\/000500780","article-title":"Final adult height after growth hormone treatment in patients with Turner syndrome","volume":"91","author":"Ahn","year":"2019","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.endien.2026.501821_bib1295","first-page":"2439","article-title":"Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height","volume":"85","author":"Chernausek","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib1300","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJM198311033091806","article-title":"A preliminary study of the effect of estrogen dose on growth in Turner's syndrome","volume":"309","author":"Ross","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.endien.2026.501821_bib1305","series-title":"Proceedings of the Pediatric Academic Societies\u2019 Annual Meeting","article-title":"Early low-dose estrogen increases adult height gain in GH-treated patients with Turner syndrome (TS): results of a double-blind, randomized placebo-controlled clinical trial","author":"Ross","year":"2007"},{"key":"10.1016\/j.endien.2026.501821_bib1310","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1210\/jc.2003-030799","article-title":"Importance of estrogen on bone health in Turner syndrome: a cross-sectional and longitudinal study using dual-energy X-ray absorptiometry","volume":"89","author":"H\u00f6gler","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib1315","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF00289473","article-title":"The distribution of chromosomal genotypes associated with Turner's syndrome: livebirth prevalence rates and evidence for diminished fetal mortality and severity in genotypes associated with structural X abnormalities or mosaicism","volume":"64","author":"Hook","year":"1983","journal-title":"Hum Genet"},{"key":"10.1016\/j.endien.2026.501821_bib1320","doi-asserted-by":"crossref","DOI":"10.1007\/BF00197261","article-title":"Mosaicism in 45, X Turner syndrome: does survival in early pregnancy depend on the presence of two sex chromosomes?","volume":"88","author":"Held","year":"1992","journal-title":"Hum Genet"},{"key":"10.1016\/j.endien.2026.501821_bib1325","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4274\/jpr.35744","article-title":"Turner syndrome and its variants","volume":"4","author":"G\u00fcrsoy","year":"2017","journal-title":"J Pediatr Res"},{"key":"10.1016\/j.endien.2026.501821_bib1330","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1210\/jc.2008-1049","article-title":"Mortality in women with Turner syndrome in Great Britain: a national cohort study","volume":"93","author":"Schoemaker","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib1335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004175","article-title":"Studying early lethality of 45, XO (Turner's syndrome) embryos using human embryonic stem cells","volume":"4","author":"Urbach","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.endien.2026.501821_bib1340","series-title":"Females are mosaics: X-inactivation and sex differences in disease","author":"Migeon","year":"2014"},{"key":"10.1016\/j.endien.2026.501821_bib1345","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s41436-018-0271-6","article-title":"Mosaic Turner syndrome shows reduced penetrance in an adult population study","volume":"21","author":"Tuke","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.endien.2026.501821_bib1350","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1542\/peds.81.3.445","article-title":"Coarctation of the aorta in Turner syndrome: a pathologic study of fetuses with nuchal cystic hygromas, hydrops fetalis, and female genitalia","volume":"81","author":"Lacro","year":"1988","journal-title":"Pediatrics"},{"key":"10.1016\/j.endien.2026.501821_bib1355","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/uog.151","article-title":"Turner's syndrome in fetal life","volume":"22","author":"Surerus","year":"2003","journal-title":"Ultrasound Obstetr Gynecol"},{"key":"10.1016\/j.endien.2026.501821_bib1360","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/(SICI)1096-8628(19970120)68:2<135::AID-AJMG3>3.0.CO;2-O","article-title":"Developmental analysis of cardiovascular system of 45, X fetuses with cystic hygroma","volume":"68","author":"Miyabara","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.endien.2026.501821_bib1365","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/jmg.2.2.142","article-title":"Karyotype\u2013phenotype correlations in gonadal dysgenesis and their bearing on the pathogenesis of malformations","volume":"2","author":"Ferguson-Smith","year":"1965","journal-title":"J Med Genet"},{"key":"10.1016\/j.endien.2026.501821_bib1370","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archpedi.1974.02110200050007","article-title":"The Ullrich\u2013Noonan syndrome (Turner phenotype)","volume":"127","author":"Nora","year":"1974","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.endien.2026.501821_bib1375","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ajmg.c.31689","article-title":"The Turner syndrome research registry: creating equipoise between investigators and participants","volume":"181","author":"Prakash","year":"2019","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.endien.2026.501821_bib1380","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1161\/CIRCIMAGING.113.000526","article-title":"Spectrum of aortic valve abnormalities associated with aortic dilation across age groups in Turner syndrome","volume":"6","author":"Olivieri","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.endien.2026.501821_bib1385","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ajmg.c.31691","article-title":"The impact of somatic mosaicism on bicuspid aortic valve and aortic dissection in Turner Syndrome","volume":"181","author":"Prakash","year":"2019","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.endien.2026.501821_bib1390","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0378-5955(00)00040-X","article-title":"Ear and hearing in relation to genotype and growth in Turner syndrome","volume":"144","author":"Barren\u00e4s","year":"2000","journal-title":"Hear Res"},{"key":"10.1016\/j.endien.2026.501821_bib1395","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00129492-200503000-00003","article-title":"Otologic disease in Turner syndrome","volume":"26","author":"Dhoodge","year":"2005","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.endien.2026.501821_bib1400","first-page":"195","article-title":"Turner syndrome genotype and phenotype and their effect on presenting features and timing of diagnosis","volume":"8","author":"Al Alwan","year":"2014","journal-title":"Int J Health Sci"},{"key":"10.1016\/j.endien.2026.501821_bib1405","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.3390\/jcm10215076","article-title":"Karyotype abnormalities in the X chromosome predict response to the growth hormone therapy in Turner syndrome","volume":"10","author":"Kasprzyk","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.endien.2026.501821_bib1410","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1530\/EJE-13-0069","article-title":"A pharmacogenomic approach to the treatment of children with GH deficiency or Turner syndrome","volume":"169","author":"Clayton","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endien.2026.501821_bib1415","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41574-019-0224-4","article-title":"Turner syndrome: mechanisms and management","volume":"15","author":"Gravholt","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.endien.2026.501821_bib1420","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3390\/diagnostics10100783","article-title":"Coexistence of growth hormone deficiency and pituitary microadenoma in a child with unique mosaic Turner syndrome: a case report and literature review","volume":"10","author":"Park","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.endien.2026.501821_bib1425","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1590\/S0004-27302008000500008","article-title":"Short stature caused by SHOX gene haploinsufficiency: from diagnosis to treatment","volume":"52","author":"Jorge","year":"2008","journal-title":"Braz Arch Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib1430","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1210\/jc.2009-1577","article-title":"Effectiveness of the combined recombinant human growth hormone and gonadotropin-releasing hormone analog therapy in pubertal patients with short stature due to SHOX deficiency","volume":"95","author":"Scalco","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib1435","doi-asserted-by":"crossref","first-page":"308","DOI":"10.6065\/apem.2346246.123","article-title":"Response of children with Turner syndrome with different types of karyotype abnormalities to growth hormone treatment","volume":"29","author":"Choi","year":"2024","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib1440","doi-asserted-by":"crossref","first-page":"13","DOI":"10.6065\/apem.2013.18.1.13","article-title":"Responses to three years of growth hormone therapy in girls with Turner syndrome","volume":"18","author":"Park","year":"2013","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib1445","series-title":"Nelson textbook of pediatrics","first-page":"2316","article-title":"Hypofunction of the ovaries","author":"Rapaport","year":"2009"},{"key":"10.1016\/j.endien.2026.501821_bib1450","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/1096-8628(20000612)96:3<373::AID-AJMG26>3.0.CO;2-Z","article-title":"Investigation of Turner syndrome in schizophrenia","volume":"96","author":"Prior","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.endien.2026.501821_bib1455","doi-asserted-by":"crossref","first-page":"42","DOI":"10.6065\/apem.2014.19.1.42","article-title":"Mosaic Turner syndrome associated with schizophrenia","volume":"19","author":"Jung","year":"2014","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib1460","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1210\/er.2006-0005","article-title":"Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers","volume":"27","author":"Cools","year":"2006","journal-title":"Endocr Rev"},{"key":"10.1016\/j.endien.2026.501821_bib1465","series-title":"Gorlin's syndromes of the head and neck","first-page":"45","article-title":"Turner syndrome","author":"Hennekam","year":"2010"},{"key":"10.1016\/j.endien.2026.501821_bib1470","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-5-8","article-title":"A review of trisomy X (47,XXX)","volume":"5","author":"Tartaglia","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.endien.2026.501821_bib1475","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3109\/09513590.2015.1018164","article-title":"The Turner syndrome in patient with 45X\/47XXX mosaic karyotype \u2013 case report","volume":"31","author":"Maciejewska-Jeske","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.endien.2026.501821_bib1480","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/jmg.39.3.217","article-title":"Phenotypic effects of mosaicism for a 47,XXX cell line in Turner syndrome","volume":"39","author":"Sybert","year":"2002","journal-title":"J Med Genet"},{"key":"10.1016\/j.endien.2026.501821_bib1485","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.clinthera.2023.12.004","article-title":"Growth hormone treatment to final height in Turner syndrome: systematic review","volume":"46","author":"Aversa","year":"2024","journal-title":"Clin Ther"},{"key":"10.1016\/j.endien.2026.501821_bib1490","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.anpedi.2014.02.020","article-title":"X isochromosomes: delayed diagnosis of Turner's syndrome","volume":"82","author":"Cuesta Hern\u00e1ndez","year":"2015","journal-title":"Anales de Pediatr\u00eda (Barcelona)"},{"key":"10.1016\/j.endien.2026.501821_bib1495","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2265.1994.tb01835.x","article-title":"Turner's syndrome with X-isochromosome and Hashimoto's thyroiditis","volume":"41","author":"De Kerdanet","year":"1994","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.endien.2026.501821_bib1500","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1044\/1059-0889(2013\/11-0027)","article-title":"Audiological abnormalities in patients with Turner syndrome","volume":"22","author":"Oliveira","year":"2013","journal-title":"Am J Audiol"},{"key":"10.1016\/j.endien.2026.501821_bib1505","series-title":"Thompson & Thompson genetics in medicine","author":"Nussbaum","year":"2007"},{"key":"10.1016\/j.endien.2026.501821_bib1510","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/sj.ejhg.5200757","article-title":"Lack of expression of XIST from a small ring X chromosome containing the XIST locus in a girl with short stature, facial dysmorphism and developmental delay","volume":"10","author":"Tomkins","year":"2002","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.endien.2026.501821_bib1515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/561974","article-title":"Hyperinsulinemic hypoglycaemia in a Turner syndrome with ring (X)","volume":"2015","author":"Cappella","year":"2015","journal-title":"Case Rep Pediatr"},{"key":"10.1016\/j.endien.2026.501821_bib1520","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/ajmg.a.35357","article-title":"Familial Xp22.33-Xp22.12 deletion delineated by chromosomal microarray analysis causes proportionate short stature","volume":"158","author":"Cho","year":"2012","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.endien.2026.501821_bib1525","doi-asserted-by":"crossref","first-page":"110","DOI":"10.6065\/apem.2015.20.2.110","article-title":"Turner syndrome presented with tall stature due to overdosage of the SHOX gene","volume":"20","author":"Seo","year":"2015","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib1530","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000381712","article-title":"Radiological features in patients with short stature homeobox-containing (SHOX) gene deficiency and Turner syndrome before and after 2 years of GH treatment","volume":"84","author":"Child","year":"2015","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.endien.2026.501821_bib1535","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.accreview.2004.12.006","article-title":"Major vascular anomalies in Turner syndrome: prevalence and magnetic resonance angiographic features","volume":"14","author":"Ho","year":"2005","journal-title":"ACC Curr J Rev"},{"key":"10.1016\/j.endien.2026.501821_bib1540","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.jacc.2008.02.035","article-title":"Aortic valve disease in Turner syndrome","volume":"51","author":"Sachdev","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.endien.2026.501821_bib1545","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1687-9856-2011-6","article-title":"Identification of factors associated with good response to growth hormone therapy in children with short stature: results from the ANSWER Program\u00ae","volume":"2011","author":"Lee","year":"2011","journal-title":"Int J Pediatr Endocrinol"},{"key":"10.1016\/j.endien.2026.501821_bib1550","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvad026","article-title":"Factors associated with response to growth hormone in pediatric growth disorders: results of a 5-year registry analysis","volume":"7","author":"Ross","year":"2023","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.endien.2026.501821_bib1555","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1210\/jcem.85.11.6976","article-title":"Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models","volume":"85","author":"Ranke","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2026.501821_bib1560","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000513788","article-title":"Prevention of growth failure in Turner syndrome: long-term results of early growth hormone treatment in the \u201ctoddler Turner\u201d cohort","volume":"94","author":"Quigley","year":"2021","journal-title":"Horm Res Paediatr"}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S253001802600171X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S253001802600171X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:49:12Z","timestamp":1792151352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S253001802600171X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":156,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S253001802600171X"],"URL":"https:\/\/doi.org\/10.1016\/j.endien.2026.501821","relation":{},"ISSN":["2530-0180"],"issn-type":[{"value":"2530-0180","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growth hormone therapy in Turner syndrome: Do cytogenetic subtypes influence outcomes?","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endien.2026.501821","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Espa\u00f1a, S.L.U. on behalf of SEEN and SED. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"501821"}}